Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

Lyell Stock

lyellbiotech.comHealthcareFounded: 2018Funding to Date: $358MM

Lyell Immunopharma is a developer of curative cell-based immunotherapies for any cancer, with a focus on CAR-Ts and solid tumors.

Learn more about Lyell IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Lyell.

Register Today

Team

Management Team

Premal Patel MD

Chief Medical Officer

Akira Matsuno

Chief Financial Officer & Head of Corporate Development

Richard Klausner MD

Founder, President, Board Member & Chief Executive Officer

Board Members

Richard Klausner MD

Robert Nelsen

ARCH Venture Partners

Cathy Friedman

Hans Bishop

Other companies like Lyell in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Precision Neuroscience

Sector

Frequently Asked Questions